Study finds patients lost more weight on Mounjaro than Ozempic (NYSE:LLY)
2024-07-08
jetcityimage A new study found that patients taking Eli Lilly’s (NYSE:LLY) Mounjaro lost significantly more weight than those taking Novo Nordisk’s (NVO) Ozempic. The study, which analyzed the electronic health records of roughly 41,000 obese or overweight patients who took the drugs, found that the mean loss in body weightContinue Reading